Literature DB >> 21819225

Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source.

Gillian SteelFisher1, Robert Blendon, Laura J Ross, Blanche C Collins, Eran N Ben-Porath, Mark M Bekheit, Johanna R Mailhot.   

Abstract

An attack with Bacillus anthracis ("anthrax") is a known threat to the United States. When weaponized, it can cause inhalation anthrax, the deadliest form of the disease. Due to the rapid course of inhalation anthrax, delays in initiation of antibiotics may decrease survival chances. Because a rapid response would require cooperation from the public, there is a need to understand the public's response to possible mass dispensing programs. To examine the public's response to a mass prophylaxis program, this study used a nationally representative poll of 1,092 adults, supplemented by a targeted focus on 3 metropolitan areas where anthrax attacks occurred in 2001: New York City (n=517), Washington, DC (n=509), and Trenton/Mercer County, NJ (n=507). The poll was built around a "worst-case scenario" in which cases of inhalation anthrax are discovered without an identified source and the entire population of a city or town is asked to receive antibiotic prophylaxis within a 48-hour period. Findings from this poll provide important signs of public willingness to comply with public health recommendations for obtaining antibiotics from a dispensing site, although they also indicate that public health officials may face several challenges to compliance, including misinformation about the contagiousness of inhalation anthrax; fears about personal safety in crowds; distrust of government agencies to provide sufficient, safe, and effective medicine; and hesitation about ingesting antibiotic pills after receiving them. In general, people living in areas where anthrax attacks occurred in 2001 had responses similar to those of the nation as a whole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21819225     DOI: 10.1089/bsp.2011.0005

Source DB:  PubMed          Journal:  Biosecur Bioterror        ISSN: 1538-7135


  6 in total

1.  Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency.

Authors:  Monica Schoch-Spana; Emily Brunson; Hannah Chandler; Gigi Kwik Gronvall; Sanjana Ravi; Tara Kirk Sell; Matthew P Shearer
Journal:  Public Health Rep       Date:  2018-05-30       Impact factor: 2.792

2.  Public response to an anthrax attack: a multiethnic perspective.

Authors:  Gillian K Steelfisher; Robert J Blendon; Amanda S Brulé; Eran N Ben-Porath; Laura J Ross; Bret M Atkins
Journal:  Biosecur Bioterror       Date:  2012-12

3.  A Learner-led, Discussion-based Elective on Emerging Infectious Disease.

Authors:  Clinton Mathias
Journal:  Am J Pharm Educ       Date:  2015-08-25       Impact factor: 2.047

4.  Model-Based Recursive Partitioning of Patients' Return Visits to Multispecialty Clinic During the 2009 H1N1 Pandemic Influenza (pH1N1).

Authors:  Osaro Mgbere; Salma Khuwaja
Journal:  Online J Public Health Inform       Date:  2020-05-16

5.  Quantitative models of the dose-response and time course of inhalational anthrax in humans.

Authors:  Damon J A Toth; Adi V Gundlapalli; Wiley A Schell; Kenneth Bulmahn; Thomas E Walton; Christopher W Woods; Catherine Coghill; Frank Gallegos; Matthew H Samore; Frederick R Adler
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

6.  Modeling Tool for Decision Support during Early Days of an Anthrax Event.

Authors:  Gabriel Rainisch; Martin I Meltzer; Sean Shadomy; William A Bower; Nathaniel Hupert
Journal:  Emerg Infect Dis       Date:  2017-01       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.